Related Experiment Video
Updated: Sep 17, 2025

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
[The burden of lung cancer in China from 1990 to 2021]
Z H Huang1, G Qiao1, Y L Zhou2
1Medical School of Nantong University, Nantong University, Department of Thoracic Surgery, Nantong Key Laboratory of Translational Medicine in Cardiothoracic Diseases, and Research Institution of Translational Medicine in Cardiothoracic Diseases, Affiliated Hospital of Nantong University, Nantong 226000, China.
Abstract:
Objective: This study aims to focus on analyzing the disease burden trends of lung cancer in China from 1990 to 2021, combined with the Socio-Demographic Index (SDI), to identify influencing factors and predict future trends, providing support for lung cancer prevention and control policies in China. Methods: The incidence, prevalence, mortality and disability-adjusted life year(DALY) of lung cancer in China from 1990 to 2021 were analyzed in conjunction with the socio-demographic index(SDI). Bayes Age-Period-Cohort model(BAPC), Auto-regressive Integrated Moving Average model(ARIMA)and frontier analysis predict future disease trends. Results: In 2021, the number of incidence of lung cancer in China will reach 934 700 (95%CI: 750 000-1 137 000), of which 622 800 (95%CI: 460 100-803 200) men and 31 900 (95%CI: 245 700-387 200) women. The number of prevalence reached 1 262 300 (95%CI: 1 055 600-1 545 300), including 836 600 men (95%CI: 616 900-1 058 700) and 425 700 women (95%CI: 333 600-533 500). The number of deaths was as high as 814 400 (95%CI: 652 600-987 800), including 546 000 (95%CI: 403 600-702 900) men and 268 400 (95%CI: 21 900-331 300) women. The number of DALY was 18 920 200 (95%CI: 15 100 700-23 11 500), of which 1 283 1900 were males (95%CI: 9 352 200-16 730 800) and 6 088 300 were females (95%CI: 4 755 100-7 606 800). In recent years, all the indicators of lung cancer disease burden have increased with the increase of years. The lung cancer disease burden is heavier with age and is significantly more common in men than women. Joinpoint analysis showed that ASMR(APC=2.21, P<0.05) and ASDR(APC=1.58, P<0.05) reached their peak in 2004. Combined with the spatial distribution of lung cancer disease burden, we found that ASIR, ASPR, ASPR and ASDR all increased with the increase of SDI. Decomposition analysis further verified that the number of deaths caused by lung cancer and the number of DALYs were more correlated with aging, while the incidence and number of cases were more correlated with epidemiological changes. Combining BAPC and ARIMA models to analyze the development of disease burden over the next 15 years, we found that the probability of ASIR and ASPR is on the rise in women, ASPR is on the rise in men, and ASDR is on the decline. Conclusion: The disease burden of lung cancer was significantly correlated with time, space, age and sex.
Related Concept Videos
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Statistical Methods for Analyzing Epidemiological Data
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
